Table 4.
Univariate and multivariate factors associated with pulmonary hypertension
| Factors | Crude odd ratio (95 % CI) | P-value | Adjusted odd ratio (95 % CI) | P-value |
|---|---|---|---|---|
| Age | 1.02 (1.00–1.06) | 0.053 | 1.03 (1.001–1.06) | 0.044 |
| AF | 2.86 (1.34–6.08) | 0.006 | - | |
| LVMI | 1.01 (1.01–1.02) | 0.002 | - | |
| LVEDV | 1.01 (1.0–1.02) | 0.052 | - | |
| LVESV | 1.03 (1.003–1.06) | 0.031 | - | |
| LAV index | 1.02 (1.01–1.03) | 0.001 | 1.01 (1.001–1.02) | 0.037 |
| TAPSE | 0.90 (0.82–0.98) | 0.013 | - | |
| EROA | 1.02 (1.01–1.03) | <0.001 | 1.02 (1.01–1.03) | 0.006 |
AF atrial fibrillation, CI confidence interval, EROA effective regurgitant orifice area, LAV left atrial volume, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVMI left ventricular mass index, TAPSE tricuspid annular plane systolic excursion